FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204648622> ?p ?o ?g. }

• W3204648622 endingPage "108160" @default.
• W3204648622 startingPage "108160" @default.
• W3204648622 abstract "Psoriasis is a chronic skin condition associated with interleukin-23/interleukin-17 (IL-23/IL-17) pathway. Recent evidence declares that angiotensin II (Ang II) induces a potent IL-17-related inflammation. Meanwhile, Losartan, an angiotensin one receptor (AT1R) antagonist, attenuates the TH17-related responses. Therefore, we investigated the possible beneficial effects of topically applied Losartan1% ointment on imiquimod (IMQ)-induced psoriasis in mice. Psoriasis was induced in mice consecutively for five days by topical IMQ on the shaved back. The IMQ-induced psoriasis was treated via topical administration of Losartan1% twice a day. The severity of skin inflammation was evaluated employing Psoriasis Area and Severity Index (PASI) scores. Subsequently, the skin samples were assessed using Baker's scoring system, stereological studies, and biochemical assessment with real-time PCR and immunohistochemistry. IMQ administration induced plaque-type psoriasis and skin inflammation. We characterized psoriatic lesions by hyperkeratosis, Munro abscess, rete ridges, and marked T-cell infiltrates. IMQ significantly increased epidermal volume, mRNA expression of IL-17a, IL-23, Ang II, AT1R, and TNF-α levels compared with the Placebo group. Topical administration of Losartan1% on IMQ-induced psoriasis significantly reduced the PASI scores and alleviated the erythema and scaling. The treatment significantly decreased the psoriatic thickness and dermal T-cell infiltration. Regarding biochemical assessment, Losartan1% considerably reduced the IMQ-induced increase of IL-17a, Ang II, and AT1R expression in the skin. Topical Losartan1% significantly alleviates psoriasis by reducing AT1R and IL-17a expression. Our results introduce AT1Rs as a promising therapeutic target in psoriasis and represent a link between angiotensin and TH17-related inflammation. However, the effects of AngII-AT1R systems on IL-17 signaling need to be confirmed by further investigations." @default.
• W3204648622 created "2021-10-11" @default.
• W3204648622 creator A5006935613 @default.
• W3204648622 creator A5014040588 @default.
• W3204648622 creator A5016672110 @default.
• W3204648622 creator A5032514843 @default.
• W3204648622 creator A5034636410 @default.
• W3204648622 creator A5034729928 @default.
• W3204648622 creator A5064720678 @default.
• W3204648622 creator A5072779510 @default.
• W3204648622 creator A5080943824 @default.
• W3204648622 date "2021-11-01" @default.
• W3204648622 modified "2023-10-10" @default.
• W3204648622 title "Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation" @default.
• W3204648622 cites W1508129365 @default.
• W3204648622 cites W1535485604 @default.
• W3204648622 cites W1939997832 @default.
• W3204648622 cites W1966248625 @default.
• W3204648622 cites W1981177225 @default.
• W3204648622 cites W2012077729 @default.
• W3204648622 cites W2022168094 @default.
• W3204648622 cites W2033544581 @default.
• W3204648622 cites W2036487040 @default.
• W3204648622 cites W2087837934 @default.
• W3204648622 cites W2090150130 @default.
• W3204648622 cites W2092300538 @default.
• W3204648622 cites W2107779094 @default.
• W3204648622 cites W2126862979 @default.
• W3204648622 cites W2165719229 @default.
• W3204648622 cites W2598808341 @default.
• W3204648622 cites W2752721387 @default.
• W3204648622 cites W2894991604 @default.
• W3204648622 cites W3003407770 @default.
• W3204648622 cites W3159546099 @default.
• W3204648622 doi "https://doi.org/10.1016/j.intimp.2021.108160" @default.
• W3204648622 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34583123" @default.
• W3204648622 hasPublicationYear "2021" @default.
• W3204648622 type Work @default.
• W3204648622 sameAs 3204648622 @default.
• W3204648622 citedByCount "12" @default.
• W3204648622 countsByYear W32046486222022 @default.
• W3204648622 countsByYear W32046486222023 @default.
• W3204648622 crossrefType "journal-article" @default.
• W3204648622 hasAuthorship W3204648622A5006935613 @default.
• W3204648622 hasAuthorship W3204648622A5014040588 @default.
• W3204648622 hasAuthorship W3204648622A5016672110 @default.
• W3204648622 hasAuthorship W3204648622A5032514843 @default.
• W3204648622 hasAuthorship W3204648622A5034636410 @default.
• W3204648622 hasAuthorship W3204648622A5034729928 @default.
• W3204648622 hasAuthorship W3204648622A5064720678 @default.
• W3204648622 hasAuthorship W3204648622A5072779510 @default.
• W3204648622 hasAuthorship W3204648622A5080943824 @default.
• W3204648622 hasConcept C126322002 @default.
• W3204648622 hasConcept C16005928 @default.
• W3204648622 hasConcept C170493617 @default.
• W3204648622 hasConcept C203014093 @default.
• W3204648622 hasConcept C2776914184 @default.
• W3204648622 hasConcept C2777011040 @default.
• W3204648622 hasConcept C2779112978 @default.
• W3204648622 hasConcept C2779121184 @default.
• W3204648622 hasConcept C2779134260 @default.
• W3204648622 hasConcept C2780288358 @default.
• W3204648622 hasConcept C2780564577 @default.
• W3204648622 hasConcept C2781228260 @default.
• W3204648622 hasConcept C2908929049 @default.
• W3204648622 hasConcept C47348012 @default.
• W3204648622 hasConcept C71924100 @default.
• W3204648622 hasConcept C98274493 @default.
• W3204648622 hasConceptScore W3204648622C126322002 @default.
• W3204648622 hasConceptScore W3204648622C16005928 @default.
• W3204648622 hasConceptScore W3204648622C170493617 @default.
• W3204648622 hasConceptScore W3204648622C203014093 @default.
• W3204648622 hasConceptScore W3204648622C2776914184 @default.
• W3204648622 hasConceptScore W3204648622C2777011040 @default.
• W3204648622 hasConceptScore W3204648622C2779112978 @default.
• W3204648622 hasConceptScore W3204648622C2779121184 @default.
• W3204648622 hasConceptScore W3204648622C2779134260 @default.
• W3204648622 hasConceptScore W3204648622C2780288358 @default.
• W3204648622 hasConceptScore W3204648622C2780564577 @default.
• W3204648622 hasConceptScore W3204648622C2781228260 @default.
• W3204648622 hasConceptScore W3204648622C2908929049 @default.
• W3204648622 hasConceptScore W3204648622C47348012 @default.
• W3204648622 hasConceptScore W3204648622C71924100 @default.
• W3204648622 hasConceptScore W3204648622C98274493 @default.
• W3204648622 hasFunder F4320327486 @default.
• W3204648622 hasLocation W32046486221 @default.
• W3204648622 hasLocation W32046486222 @default.
• W3204648622 hasOpenAccess W3204648622 @default.
• W3204648622 hasPrimaryLocation W32046486221 @default.
• W3204648622 hasRelatedWork W2039876145 @default.
• W3204648622 hasRelatedWork W2119329430 @default.
• W3204648622 hasRelatedWork W2127097079 @default.
• W3204648622 hasRelatedWork W2129316781 @default.
• W3204648622 hasRelatedWork W2800433676 @default.
• W3204648622 hasRelatedWork W2980573764 @default.
• W3204648622 hasRelatedWork W2999042028 @default.
• W3204648622 hasRelatedWork W3154839791 @default.
• W3204648622 hasRelatedWork W3181863490 @default.

• next